+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Europe Cell Line Development Serum Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type; By Application; and Country

  • PDF Icon

    Report

  • 103 Pages
  • December 2020
  • Region: Europe
  • The Insight Partners
  • ID: 5236413
UP TO OFF until Jun 30th 2024
According to a new market research study of “Europe Cell Line Development Serum Market Forecast to 2027 - COVID-19 Impact and Analysis by Type and Application.”The Europe cell line development serum market is expected to reach US$ 422.61 Mn in 2027 from US$ 268.68 Mn in 2019. The market is estimated to grow with a CAGR of 5.9% from 2020 to 2027. The report highlights trends prevailing in the Europe cell line development serum market and the factors driving market along with those that act as hindrances.

The Europe cell line development serum market, based on type, has been segmented into fetal bovine serum, adult bovine serum, porcine serum, horse serum, other animal serum. Fetal bovine serum segment held the largest share and is expected to register the highest CAGR in the market during the forecast period.

The cell line can be defined as cell culture, selected for uniformity from a cell population derived from a usually homogeneous tissue source in a growing medium under controlled conditions. The serum serves as a carrier for enzymes, micronutrients, lipids, and trace elements into the cell and regulates cell membrane permeability. Tissue Engineering has now evolved into the broader area of regenerative medicine, which focuses on developing clinical therapies for the maintenance, repair, replacement, and enhancement of biological function, using cell engineering. Regenerative therapies using cell lines and culture can help the researchers in early-intervention treatment for degenerative diseases and traumatic injuries. Thus, a surge in the use of regenerative medicines propels the cell line development serum market.

Key factors that are driving growth of the Europe cell line development serum market are increasing adoption of regenerative medicines, rising prevalence of cancer across the globe and increasing investments in R&D by pharmaceutical and biotechnology companies. However, risks associated with cell line contamination is expected to hamper the market during the forecast period.

Lonza, Thermo Fisher Scientific Inc. and Sigma-Aldrich Corporation (Merck KGaA) are among the leading companies operating in the Europe cell line development serum market.

The report segments in Europe Cell Line Development Serum Market as follows:

By Type
  • Fetal Bovine Serum
  • Adult Bovine Serum
  • Porcine Serum
  • Horse Serum
  • Other Animal Serum

By Application
  • Bioproduction
  • Drug Discovery
  • Tissue Engineering and Regenerative Medicines
  • Toxicity Testing
  • Academic Research

By Country
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific Sophorolipid Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Sophorolipid Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the sophorolipid market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Cell Line Development Serum Market - By Type
1.3.2 Europe Cell Line Development Serum Market - By Application
1.3.3 Europe Cell Line Development Serum Market - By Country

2. Cell Line Development Serum Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Cell Line Development Serum - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe
4.3 Expert Opinion

5. Cell Line Development Serum Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Adoption of Regenerative Medicines
5.1.2 Rising R&D Investments and Collaborations Among Pharmaceutical and Biotechnology Companies
5.2 Key Restraints
5.2.1 Risk of Contamination, Misidentification, and Random Alternations in Cell Lines
5.3 Key Opportunities
5.3.1 Increasing Vaccine Production
5.4 Future Trends
5.4.1 Drug Development and Adoption of Novel Technologies for Cell Line Development
5.5 Impact Analysis

6. Cell Line Development Serum Market - Europe Analysis
6.1 Europe Cell Line Development Serum Market Revenue Forecast and Analysis

7. Cell Line Development Serum Market - Revenue and Forecasts to 2027 - Type
7.1 Overview
7.2 Europe Cell Line Development Serum Market, by Type, 2019 & 2027 (% Share)
7.3 Fetal Bovine Serum
7.3.1 Overview
7.3.2 Europe Fetal Bovine Serum Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Adult Bovine Serum
7.4.1 Overview
7.4.2 Europe Adult Bovine Serum Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Porcine Serum
7.5.1 Overview
7.5.2 Global Porcine Serum Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Horse Serum
7.6.1 Overview
7.6.2 Europe Horse Serum Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Other Animal Serum
7.7.1 Overview
7.7.2 Europe Other Animal Serum Market Revenue and Forecast to 2027 (US$ Mn)

8. Cell Line Development Serum Market Analysis and Forecasts to 2027 - Application
8.1 Overview
8.2 Europe Cell Line Development Serum Market Share by Application 2019 & 2027 (%)
8.3 Drug Discovery
8.3.1 Overview
8.3.2 Europe Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Bioproduction
8.4.1 Overview
8.4.2 Europe Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Tissue Engineering and Regenerative Medicines
8.5.1 Overview
8.5.2 Europe Tissue Engineering and Regenerative Medicines Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Toxicity Testing
8.6.1 Overview
8.6.2 Europe Toxicity Testing Revenue and Forecast to 2027 (US$ Mn)
8.7 Academic Research
8.7.1 Overview
8.7.2 Europe Academic Research Revenue and Forecast to 2027 (US$ Mn)

9. Cell Line Development Serum Market Revenue and Forecast to 2027 - Europe Analysis
9.1 Europe Cell Line Development Serum Market Revenue and Forecast to 2027
9.1.1 Europe Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.2 Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.1.3 Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.1.4 Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Country (%)
9.1.5 Germany Cell Line Development Serum Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.1 Germany Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.5.2 Germany Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.1.5.3 Germany Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.1.6 UK Cell Line Development Serum Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 UK Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.6.2 UK Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.1.6.3 UK Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.1.7 France Cell Line Development Serum Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 France Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.7.2 France Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.1.7.3 France Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.1.8 Spain Cell Line Development Serum Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Spain Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.8.2 Spain Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.1.8.3 Spain Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.1.9 Italy
9.1.9.1 Italy Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.9.2 Italy Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.1.9.3 Italy Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.1.10 Rest of Europe
9.1.10.1 Rest of Europe Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.10.2 Rest of Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.1.10.3 Rest of Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)

10. Impact Of COVID-19 Pandemic on Europe Cell Line Development Serum Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic

11. Company Profiles
11.1 Lonza
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Thermo Fisher Scientific Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Sigma-Aldrich Corporation (Merck KGaA)
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 PAN Biotech.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Cytiva (Danaher)
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Corning Incorporated
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 European Collection of Cell Cultures (ECACC)
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 WuXi AppTec
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 American Type Culture Collection (ATCC)
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments

12. Appendix
12.1 About the Publisher
12.2 Glossary of Terms

List of Tables
Table 1. Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 2. Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 3. Germany Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 4. Germany Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 5. UK Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 6. UK Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 7. France Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 8. France Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 9. Spain Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 10. Spain Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 11. Italy Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 12. Italy Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 13. Rest of Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 14. Rest of Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 15. Glossary of Terms, Cell Line Development Serum MarketList of Figures
Figure 1. Cell Line Development Serum Market Segmentation
Figure 2. Cell Line Development Serum Market Segmentation, By Region
Figure 3. Europe Cell Line Development Serum Market Overview
Figure 4. Fetal Bovine Serum Segment Held Largest Share of Type Segment in Cell Line Development Serum Market
Figure 5. Europe Cell Line Development Serum Market- Leading Country Markets (US$ Mn)
Figure 6. Europe
Figure 7. Cell Line Development Serum Market Impact Analysis of Driver and Restraints
Figure 8. Europe Cell Line Development Serum Market - Revenue Forecast and Analysis - 2019- 2027
Figure 9. Europe Cell Line Development Serum Market, Type, 2019 & 2027 (% Share)
Figure 10. Europe Fetal Bovine Serum Market Revenue and Forecast to 2027 (US$ Mn)
Figure 11. Europe Adult Bovine Serum Market Revenue and Forecast to 2027 (US$ Mn)
Figure 12. Global Porcine Serum Market Revenue and Forecast to 2027 (US$ Mn)
Figure 13. Europe Horse Serum Market Revenue and Forecast to 2027 (US$ Mn)
Figure 14. Europe Other Animal Serum Market Revenue and Forecast to 2027 (US$ Mn)
Figure 15. Europe Cell Line Development Serum Market Share by Application 2019 & 2027 (%)
Figure 16. Europe Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
Figure 17. Europe Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
Figure 18. Europe Tissue and Regenerative Medicines Engineering Market Revenue and Forecast to 2027 (US$ Mn)
Figure 19. Europe Toxicity Testing Market Revenue and Forecast to 2027 (US$ Mn)
Figure 20. Europe Academic Research Market Revenue and Forecast to 2027 (US$ Mn)
Figure 21. Europe Cell Line Development Serum Market Revenue, By Country, 2019 (US$ Mn)
Figure 22. Europe Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 23. Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Country (%)
Figure 24. Germany Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 25. UK Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 26. France Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 27. Spain Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 28. Italy Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 29. Rest of Europe Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 30. Impact of COVID-19 Pandemic in European Country Markets

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Lonza
  • Thermo Fisher Scientific Inc.
  • Sigma-Aldrich Corporation (Merck KGaA)
  • Cytiva (Danaher)
  • Corning Incorporated
  • European Collection of Cell Cultures (ECACC)
  • WuXi AppTec
  • American Type Culture Collection (ATCC)